Preparing for your consultation : Before your appointment, document: Your weight history, including previous weight loss attempts and outcomes Current medications and medical conditions Perimenopausal symptoms and their impact on daily life Dietary habits and physical activity levels Family history of obesity, diabetes, or thyroid conditions Specific concerns about weight gain and health goals Questions to discuss with your GP : "Am I eligible for referral to specialist weight management services that might consider GLP-1 medications?" "What are the realistic expectations for weight loss with these treatments?" "How would this medication interact with any HRT or other treatments I'm taking?" "What monitoring would be required during treatment?" "What happens when I stop the medicationwill weight return?" "Are there local NHS weight management services that might help?" "Would addressing my perimenopausal symptoms with HRT potentially help with my overall health?" Setting realistic expectations is crucial

Wu W, et al
Defective ZDHHC21 function protects renal function and structure during sepsis injury by attenuating the reduction of renal blood flow, renal perfusion, and renal oxygen saturation
Drugs@FDA: Approval updates for GLP-1 receptor agonists for diabetes and chronic weight management
A fixed-effects model was used when the heterogeneity was considered to be significant (, when represented the sum of identical heterogeneity across all studies and represented the sum of sampling error across all studies ( Quality of evidence We evaluated the quality and strength of the evidence for each outcome based on the Graded Recommendations Assessment, Development and Evaluation (GRADE) method
In a study conducted by The IAMS Company, overweight dogs were fed similar diets